|
Verzögert
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 22.20 USD | -0.89% |
|
-0.98% | -11.24% |
| 13.01. | Nxera Pharma erhält Meilensteinzahlung in Höhe von 3,6 Millionen US-Dollar von Centessa | MT |
| 11.12. | Centessa Pharmaceuticals plc ernennt Mario Alberto Accardi zum CEO | RE |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | - | - | - | -73.93% | - | 1.87x | |
| 7.25 Mrd. | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | |
| 15.4 Mrd. | 8.91% | 20.12% | 33.53% | 5.12% | 3.33x | |
| 3.81 Mrd. | -16.92% | -14.91% | -18.77% | -11% | 4.06x | |
| 2.41 Mrd. | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | |
| 2.11 Mrd. | 19.17% | 21.38% | 58.42% | 21.52% | -1.39x | |
| 7.2 Mrd. | 5.84% | 14.63% | 7.8% | 3.73% | 1.93x | |
| 8.28 Mrd. | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | |
| 376 Mio. | -103.97% | -76.66% | - | -37.71% | -1.14x | |
| 693 Mio. | -107.63% | -20.47% | - | -25.37% | 0.13x | |
| 705 Mio. | -64.4% | -67.38% | -93.12% | -15.15% | 2.26x | |
| 4.05 Mrd. | 0.25% | 19.9% | 15.1% | 6.78% | 2.05x | |
| 1.22 Mrd. | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| 1.98 Mrd. | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | |
| Durchschnitt | 4.27 Mrd. | -16.72% | 0.6% | -1.72% | -1.51% | 1.31x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 5.69 Mrd. | -8.18% | 4.36% | 5.67% | -0.54% | 1.74x |
- Börse
- Aktien
- A3CQ72 Aktie
- Sektor Centessa Pharmaceuticals plc
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben